New national holding QazBioPharm is going to support biological safety, sustainable development and improvement of biopharmaceutical market infrastructure in Kazakhstan, according to the government decree, which has been published on the website adilet.zan.kz.
In the decree the government has determined the scope of responsibilities of the new holding as promotion of biopharmaceutical science and industry; meeting the needs of the state and society of biopharmaceutical products.
The authorized capital of the holding must be formed by shares of the Scientific Center of Anti-Infective Drugs which belonged to the government of Kazakhstan.
Also, the government has ordered the Committee of State...